210 related articles for article (PubMed ID: 25589800)
1. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels.
Pruthi A; Choudhury PS; Gupta M; Taywade S
Indian J Nucl Med; 2015; 30(1):16-20. PubMed ID: 25589800
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
Karantanis D; Bogsrud TV; Wiseman GA; Mullan BP; Subramaniam RM; Nathan MA; Peller PJ; Bahn RS; Lowe VJ
J Nucl Med; 2007 Jun; 48(6):896-901. PubMed ID: 17504869
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
5. Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake.
Jeong YH; Kim D; Lee JW; Rhee Y; Nam KH; Yun M; Kim CK
Clin Nucl Med; 2015 Aug; 40(8):632-6. PubMed ID: 26018720
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT.
Ding Y; Wu S; Xu J; Wang H; Ma C
Nucl Med Commun; 2019 Jan; 40(1):57-62. PubMed ID: 30422898
[TBL] [Abstract][Full Text] [Related]
8.
Eshghi N; Garland LL; Nia E; Betancourt R; Krupinski E; Kuo PH
J Nucl Med Technol; 2018 Sep; 46(3):260-264. PubMed ID: 29599403
[TBL] [Abstract][Full Text] [Related]
9. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
10.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
11. Correlation of BRAF mutation and SUV
Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
Kim SS; Kim SJ; Bae YT; Lee JY; Kim BH; Kim YK; Kim IJ
Thyroid; 2012 Jan; 22(1):53-8. PubMed ID: 22142373
[TBL] [Abstract][Full Text] [Related]
14. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images.
Yaylali O; Kirac FS; Yuksel D; Marangoz E
Indian J Cancer; 2014; 51(3):236-240. PubMed ID: 25494112
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
17. Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on PET-CT.
Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Inoue T; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):894-902. PubMed ID: 19156410
[TBL] [Abstract][Full Text] [Related]
18. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
19. Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.
Lee JY; Choi JY; Choi YH; Hyun SH; Moon SH; Jang SJ; Choe YS; Lee KH; Kim BT
Korean J Radiol; 2013; 14(3):501-9. PubMed ID: 23690721
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
